Dawnrays Pharmaceutical to Sell Entire 35% Stake in AD Pharmaceuticals for CNY267.39M
Dawnrays Pharmaceutical to Sell Entire 35% Stake in AD Pharmaceuticals for CNY267.39M
东瑞制药将以人民币2.6739亿元出售AD Pharmicals全部35%的股份
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册